Clinical study designs in the urologic literature: A review for the practicing urologist

Urology

Volumn 55, Issue 4, 2000, Pages 468-476

  Rosenberg, Andrew L ^a   Wei, John T ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CASE CONTROL STUDY; CLINICAL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; REVIEW; UROLOGY;

CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; GUIDELINES; HUMANS; RESEARCH DESIGN; UROLOGY;

EID: 0034100015     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00599-3     Document Type: Review

References (26)

1. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer a multi-institutional update . JAMA. 277:1997;1445-1451.
2. Tornblom M., Norming U., Adolfsson J., et al. Diagnostic value of percent free prostate-specific antigen retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL . Urology. 53:1999;945-950.
3. Gordis L. Epidemiology. 1996;170-182 WB Saunders, Philadelphia.
4. Gordis L., Kleinman J.C., Klerman L.V., et al. Criteria for evaluating evidence regarding the effectiveness of prenatal interventions. Merkatz I.R., Thompson J.E. New Perspectives on Prenatal Care. 1990;31-38 Elsevier, New York.
5. Bailar J.C. Introduction to clinical trials. Shapiro S.H., Louis T.A. Clinical Trials Issues and Approaches . 1983;1-11 Marcel Dekker, New York.
6. Case R.A.M., Hosker M.E. Tumors of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Br J Indust Med. 11:1954;75-104.
7. Cohen S.M. Urinary bladder carcinogenesis. Toxicol Pathol. 26:1998;121-127.
8. Rosenberg L., Palmer J.R., Zauber A.G., et al. The relation of vasectomy to the risk of cancer. Am J Epidemiol. 140:1994;431-438.
9. Lesko S.M., Louik C., Vezina R., et al. Vasectomy and prostate cancer. J Urol. 161:1999;1848-1852.
10. Zhu K., Stanford J.L., Daling J.R., et al. Vasectomy and prostate cancer a case-control study in a health maintenance organization . Am J Epidemiol. 144:1996;717-722.
11. Moller H., Skakkebaek N.E. Risk of testicular cancer in subfertile men case-control study . Br Med J. 318:1999;559-562.
12. Peipert J.F., Phipps M.G. Observational studies. Clin Obstet Gynecol. 41:1998;235-244.
13. Koppie T.M., Shinohara K., Grossfeld G.D., et al. The efficacy of cryosurgical ablation of prostate cancer the University of California, San Francisco experience . J Urol. 162:1999;427-432.
14. Stein P.C., Torri A., Parsons C.L. Elevated urinary norepinephrine in interstitial cystitis. Urology. 53:1999;1140-1143.
15. Nyberg L.M. Advances in the diagnosis and management of interstitial cystitis. Stephen R. Urology Annual. 1991;181-191 Appleton & Lange, Norwalk, Connecticut.
16. Jacobsen S.J., Bergstralh E.J., Katusic S.K., et al. Screening digital rectal examination and prostate cancer mortality - a population-based case-control study. Urology. 52:1998;173-179.
17. Gann P.H., Hennekens C.H., Stampfer M.J. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA. 273:1995;289-294.
18. Michaud D.S., Spiegelman D., Clinton S.K., et al. Fluid intake and the risk of bladder cancer in men. N Engl J Med. 340:1999;1390-1397.
19. Miller M.I., Puchner P.J. Effects of finasteride on hematuria associated with benign prostatic hyperplasia long-term follow-up . Urology. 51:1998;237-240.
20. Sieber P.R., Rommel F.M., Huffnagle H.W., et al. The treatment of gross hematuria secondary to prostatic bleeding with finasteride. J Urol. 159:1998;1232-1233.
21. Schwartz E.J., Lepor H. Radical retropubic prostatectomy reduces symptom scores and improves quality of life in men with moderate and severe lower urinary tract symptoms. J Urol. 161:1999;1185-1188.
22. McConnell J.D., Bruskewitz R., Walsh P., et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med. 338:1998;557-563.
23. Peduzzi P., Wittes J., Detre K., et al. Analysis as randomized and the problem of non-adherence an example from the Veterans Affairs Randomized Trial of Coronary Artery Bypass Surgery . Stat Med. 12:1993;1185-1195.
24. Pocock S.J. Clinical Trials A Practical Approach . 1984;John Wiley & Sons, New York.
25. Blumenstein B.A. The randomized clinical trial. Oesterling J.E., Richie J.P. Urologic Oncology. 1997;792-800 WB Saunders, Philadelphia.
26. Friberg S., Taube A., Sylvester R., et al. Analysis and presentation. Urology. 49:(suppl 4A):1997;54-65.